Tag:
Royal DSM
Latest Headlines
Latest Headlines
Kensey Nash shareholder sues to block company's $360M sale to DSM
A week ago Dutch company Royal DSM ($DSM) announced with plenty of fanfare that it would fork over $360 million in cash for Kensey Nash ($KNSY). But a Kensey Nash investor is now suing to block the sale.
DSM swoops in with $360M offer for Kensey Nash
Dutch company Royal DSM ($DSM) has agreed to cough up $360 million in cash for Exton, PA-based Kensey Nash ($KNSY), a player in regenerative medicine.
UPDATED: Crucell and Royal DSM pull the plug on biosimilar JV
A joint venture marrying the protein and antibody development technology of Crucell with the manufacturing knowhow of Royal DSM has collapsed.
Royal DSM injects delivery tech into scar-reduction alliance
In an expansion of its growing body of work in drug delivery, Dutch materials giant Royal DSM has struck a deal with AdeTherapeutics to advance development of treatments for pain management and scar
Biomax Informatics expands deal with Royal DSM
German R&D software firm Biomax Informatics and Dutch chemical industry giant Royal DSM plan to expand a deal under which DSM will license Biomax's BioXM system for tools used in synthetic
DSM to acquire Polymer Technology Group
Amsterdam-based Royal DSM has inked a deal to buy the Polymer Technology Group in Berkeley, CA, making it a world leader in polymers for biomedical research. The financial details were not
